Immunohistochemical markers of thyroid tumors can be divided into two major categories: those related to the cell types and those related to the type of pathology. The most important markers in the first category are thyroglobulin and TTF-1 for follicular cells, and calcitonin, CEA, and chromogranin for C cells. Markers in the second category are primarily directed at papillary carcinoma and include cytokeratin 19, high-molecular weight keratin (identifiable with antibody 34βE12), S-100 protein, HBME-1, galectin 3, and p27kip1. At the practical level, cell type-related markers are much more useful than disease-related markers. Markers said to be of prognostic value in medullary carcinomas are calcitonin, bcl-2, and N-myc.
ChanJ.K.C., RosaiJ.: Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept. Hum Pathol, 22: 349–367, 1991.
4.
LaGuetteJ., Matias-GuiuX., RosaiJ.: Thyroid paraganglioma: a clinicopathologic and immunohistochemical study of three cases. Am J Surg Pathol, 21: 748–753, 1997.
5.
Matias-GuiuX., LaGuetteJ., Puras-GilA.M., RosaiJ.: Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases. Am J Surg Pathol, 21: 754–762, 1997.
6.
RobboyS.J., ScullyR.E.: Strumal carcinoid of the ovary: an analysis of 50 cases of a distinctive tumor composed of thyroid tissue and carcinoid. Cancer, 46: 2019–2034, 1980.
7.
HeffnerD.K.: Low-grade adenocarcinoma of probable endolymphatic sac origin: a clinicopathologic study of 20 cases. Cancer, 69: 2292–2302, 1989.
8.
BeesleyM.F., McLarenK.M.: Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology, 41: 263–243, 2002.
9.
EricksonL.A., YousefO., JinL., LohseC.M., PankratzV.S., LloydR.V.: p27kipl expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma. Mod Pathol, 13: 1014–1019, 2000.
10.
ErkilcS., AydinA., KocerE.: Diagnostic utility of cytokeratin 19 expression in multinodular goiter with papillary areas and papillary carcinoma of thyroid. Endocr Pathol, 13: 207–212, 2002.
11.
HermannM.E., LiVolsiV.A., PashaT.L., RobertsS.A., WojcikE.M., BalochZ.W.: Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med, 126: 710–713, 2002.
12.
RoriveS., EddafaliB., FernandezS., DecaesteckerC., AndreS., KaltnerH., KuwabaraI., LiuF.T., GabiusH.J., KissR., SalmonI.: Changes in galectin-7 and cytokeratin-19 expression during the progression of malignancy in thyroid tumors: diagnostic and biological implications. Mod Pathol, 15: 1294–1301, 2002.
13.
DamianiS., FratamicoF., LapertosaG., DinaR., EusebiV.: Alcian blue and epithelial membrane antigen are useful markers in differentiating benign from malignant papillae in thyroid. Virchows Arch, 419: 131–135, 1991.
ArifS., BlandesA., Diaz-CanoS.J.: Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma. Histopathology, 41: 357–263, 2002.
16.
SahooS., HodaS.A., RosaiJ., DeLellisR.: Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma. A note of caution. Am J Clin Pathol, 116: 696–702, 2001.
CerilliL.A., MillsS.E., RumpelC.A., DudleyT.H., MoskalukC.A.: Interpretation of RET immunostaining in follicular lesions of the thyroid. Am J Clin Pathol, 118: 186–193, 2002.
19.
PykeC.M., HayI.D., GoellnerJ.E., BergstralhE.J., van HeerdenJ.A., GrantC.S.: Prognostic significance of calcitonin immunoreactivity, amyloid staining, and flow cytometric DNA measurements in medullary thyroid carcinoma. Surgery, 110: 964–971, 1991.
20.
RoncalliM., VialeG., GrimeliusL., JohanssonH., WilanderE., AlfanoR.M., SpringallD., BattezzatiP.M., PolakJ.M., CoggiG.: Prognostic value of N-myc immunoreactivity in medullary thyroid carcinoma. Cancer, 74: 134–141, 1994.
21.
VialeG., RoncalliM., GrimuliusL, GrazianiD., WilanderE., JohanssonH., BergholmU., CoggiG.: Prognostic value of Bcl-2 immunoreactivity in medullary thyroid carcinoma. Hum Pathol, 26: 945–950, 1995.
22.
HosaiS.A., ApelR.L., FreemanJ.L., AzadianA., RosenI.B., LiVolsiV.A., AsaSl: Immunohistochemical localization of p53 in human thyroid neoplasms: correlation with biological behavior. Endocr Pathol, 8: 21–28, 1997.
